Welcome to our dedicated page for Neon Bloom news (Ticker: NBCO), a resource for investors and traders seeking the latest updates and insights on Neon Bloom stock.
Neon Bloom, Inc. (OTC PINK: NBCO) issues frequent updates that outline its evolution from a life-science and cannabis-derived ingredient business toward a stronger emphasis on financial services and financial transaction processing. Its news flow highlights developments at its wholly owned subsidiary Advanced Executive Sales (AES), as well as strategic decisions such as acquisitions, divestments, and technology upgrades.
Recent announcements describe Neon Bloom’s focus on e-commerce and point-of-sale transaction solutions through AES, including the integration of an AI-driven backend software package and multi-factor authentication across its payment processing platforms. The company states that these changes are intended to reduce fraud, increase capacity, and manage vendor redundancy and charge-backs, while supporting expansion into additional areas of the fintech industry.
News items also cover Neon Bloom’s relationships with partners such as YNLO Ultratech, Payshield, Genwin LLC, and Elevated International. These relationships are described as providing back-end development software, transactional solutions, and third-party business development support in e-commerce, enterprise, and retail environments, with the goal of increasing transactional volume and yearly revenue.
Earlier releases provide context on Neon Bloom’s involvement in life-science technologies through Bazelet Health Systems Inc., including work on the patented PAN2020 cannabis plant and the PECSA ingredient, as well as the subsequent divestment of Bazelet as the company shifted its primary focus to financial services. Visitors to this news page can review a chronological archive of these corporate updates, technology implementations, partnership announcements, and strategic transactions related to NBCO.
Neon Bloom Inc. (OTC: NBCO) announced that its subsidiary, Bazelet Health Systems, will exhibit at the National Restaurant Association Show from May 21-24, 2022, in Chicago. Bazelet aims to introduce PECSA™, a plant-based, non-GMO ingredient derived from THC-free patented plants, targeting the global demand for natural food and beverage products. PECSA™ promotes EndoCannabinoid System health, offering a zero-THC solution for the 95% of the population that avoids cannabis with THC. Bazelet is focusing on establishing customer relationships and expanding its market presence.
Neon Bloom (OTC: NBCO) announces that its subsidiary Bazelet Health Systems has produced Cannabis America, a 100% THC-free cannabis plant. Tested by ACS Laboratory, this unique plant allows legal agricultural growth without the risk of THC contamination. Cannabis America offers versatile uses in industries like textiles, construction, and food production, contributing to carbon reduction as a natural purifier. Bazelet also develops PECSA™, a non-GMO food ingredient derived from this plant, targeting global markets. The company aims to fulfill the rising demand for zero-THC products in various sectors.
Neon Bloom Inc. (OTC: NBCO) has appointed Walter Tabaschek as Chief Operating & Financial Officer of its subsidiary, Bazelet Health Systems, Inc. Tabaschek joins from Bunge LTD., where he held significant roles, including COO of the Financial Services Group. He aims to spearhead Bazelet's operations and financial strategy, focusing on the marketing of PECSA™, a unique cannabis ingredient. Tabaschek is actively engaging investors at the Benzinga Cannabis Capital Conference, showcasing Bazelet's innovations in federally legal cannabis products.
Neon Bloom Inc. (OTC: NBCO) announces the launch of PECSA™, a first-to-market, federally legal cannabis ingredient developed by its subsidiary, Bazelet Health Systems, Inc. PECSA™, a plant-based, patent-pending ingredient, is designed for the food, drug, tobacco, and cosmetic industries and contains zero THC and CBD. It aims to support the Endocannabinoid System, potentially benefiting various health conditions. The ingredient will be supplied to enterprises interested in incorporating legal cannabinoid-derived ingredients into their products. PECSA™ is derived from the patented Pan2020 cannabis plant, ensuring compliance with federal regulations.
Neon Bloom, through its subsidiary Bazelet Health Systems, is enhancing the cannabis industry with non-psychoactive products. On January 3, 2022, the company received shareholder consent to amend its Articles of Incorporation, increasing its authorized shares to 750 million and creating 2 million shares of Series B Preferred stock. Bazelet is at the forefront of cannabis genome engineering, utilizing CRISPR technology to develop patented therapeutic plants that comply with federal regulations.
Neon Bloom (OTC: NBCO) has entered a licensing agreement with Floresta, LLC to cultivate Panakeia™ plants, unique cannabis genetics with 0.00% THC, at a facility in Tallahassee, Florida. This development positions Bazelet Health Systems, its subsidiary, to enhance its relationship with the FDA by supporting research on cannabis products. The initiative aims to contribute to FDA studies focused on the safety and efficacy of non-psychoactive cannabis. Additionally, part of the plants will support educational initiatives in cannabis research in Florida.
Bazelet Health Systems announced that its cannabis genetics excelled in Cornell University's "2021 Fiber and Dual-Purpose Strip Trials", leading in metrics like seed weight and germination rates. Notably, Bazelet's genetics had a seed weight over 20% greater than competitors and a germination rate of 88%. The varieties also reported nearly double the plant density, with heights 1.5 times taller than other strains. This success highlights Bazelet's commitment to developing non-psychoactive cannabis aimed at transforming agriculture and the food supply chain.
Bazelet Health Systems, a subsidiary of Neon Bloom (OTC:NBCO), has partnered with Sattviko to create a new line of superfoods infused with non-psychoactive cannabis ingredients. This collaboration aims to market healthy snacks that are diabetic-friendly, gluten-free, and packed with nutrients. The products will launch in the U.S. and globally in late 2021, supporting an expected growth in the superfoods market, projected to surpass $200 billion within five years. This partnership positions both companies at the forefront of the global superfood revolution.
Bazelet Research, a subsidiary of Neon Bloom (OTC: NBCO), has initiated advanced plant breeding for THC-Free cannabis cultivars aimed at regional adaptation in the Southeast U.S. The goal is to create safe 0.00% THC strains for the legal hemp market. The company boasts a 15,000 sf plant tissue culture lab and utilizes cutting-edge CRISPR gene-editing technology. Supported by the USDA, this initiative aims to enhance plant production and sustainable agriculture, addressing emerging demands in various industries.
Bazelet Oglesby, a subsidiary of Neon Bloom, Inc. (OTC: NBCO), has partnered with Mobile Hemp Drying Company (MHD) to enhance its Plant Science Service Plan. This collaboration will provide premium post-harvest hemp drying services utilizing advanced LMC Manufacturing equipment. MHD's system is designed to maintain optimal cannabinoid integrity during the drying process. CEO Ryan Kelly praised Bazelet's advancements in the hemp industry, while Bazelet’s Director, Kirk Calvert, highlighted the benefits of this service in terms of cost savings and risk reduction for customers.